Stage-specific embryonic antigen-4 is a histological marker reflecting the malignant behavior of prostate cancer.
Stage-specific embryonic antigen-4 is a histological marker reflecting the malignant behavior of prostate cancer.
复制标题
阶段特异性胚胎抗原4是反映前列腺癌恶性行为的组织学标志物。
DOI:
10.1007/s10719-019-09882-2
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
Sakai H.
中科院分区:
文献类型:
--
作者:
Nakamura Y;Miyata Y;Matsuo T;Shida Y;Hakariya T;Ohba K;Taima T;Ito A;Suda T;Hakomori SI;Saito S;Sakai H.
Stage-specific embryonic antigen-4 (SSEA-4), a specific marker for pluripotent stem cells, plays an important role in the malignant behavior of several cancers. Here, SSEA-4 expression was evaluated by immunohistochemistry using monoclonal antibody RM1 specific to SSEA-4 in 181 and 117 prostate cancer (PC) specimens obtained by biopsy and radical prostatectomy (RP), respectively. The relationships between SSEA-4 expression in cancer cells or the presence of SSEA-4-positive tumor-infiltrating immune cells (TICs) and clinicopathological parameters were analyzed. SSEA-4 expression in cancer cells was significantly associated with Gleason score, local progression, and lymph node and distant metastasis. In RP specimens, high SSEA-4 expression in cancer cells and the presence of SSEA-4-positive TICs were significant predictors of pT3,i.e., invasion and worse biochemical recurrence (BCR) after RP, respectively, in univariate analysis. In contrast, combination of high SSEA-4 expression in cancer cells and the presence of SSEA-4-positive TICs was an independent predictor for pT3 and BCR in multivariate analysis. Biologically this combination was also independently associated with suppression of apoptosis. Thus, the co-expression of SSEA-4 in cancer cells and TICs may have crucial roles in the malignant aggressiveness and prognosis of PC. Invasive potential and suppression of apoptosis may be linked to SSEA-4 expression.